MK-5757

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-5757, covering 2010-12-15 to 2010-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED) [Phase 2]